147 related articles for article (PubMed ID: 30979789)
1. Difficult case: rituximab in anti-SRP antibody myositis in pregnancy.
Mehta P; Dorsey-Campbell R; Dassan P; Nelson-Piercy C; Viegas S
Pract Neurol; 2019 Oct; 19(5):444-446. PubMed ID: 30979789
[TBL] [Abstract][Full Text] [Related]
2. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.
Valiyil R; Casciola-Rosen L; Hong G; Mammen A; Christopher-Stine L
Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1328-34. PubMed ID: 20506493
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab.
Aggarwal R; Oddis CV; Goudeau D; Koontz D; Qi Z; Reed AM; Ascherman DP; Levesque MC
Rheumatology (Oxford); 2016 Jun; 55(6):991-9. PubMed ID: 26888854
[TBL] [Abstract][Full Text] [Related]
4. Rituximab therapy in necrotizing autoimmune myopathy associated with anti-SRP antibody: A clinical case review.
Nóvoa Medina FJ; Gutiérrez Martínez J; González González Y; Romero Díaz B; Machín García S; Rosas Romero A
Reumatol Clin (Engl Ed); 2018; 14(6):379-381. PubMed ID: 28389200
[TBL] [Abstract][Full Text] [Related]
5. Recovery from severe dysphagia in systemic sclerosis - myositis overlap: a case report.
Chinniah KJ; Mody GM
Afr Health Sci; 2017 Jun; 17(2):593-596. PubMed ID: 29062359
[TBL] [Abstract][Full Text] [Related]
6. Anti-SRP-positive necrotising myopathy concurrent with breast malignancy.
Dandasena T; Ingle V; Singhai A; Saigal S
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38081733
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.
Pinal-Fernandez I; Parks C; Werner JL; Albayda J; Paik J; Danoff SK; Casciola-Rosen L; Christopher-Stine L; Mammen AL
Arthritis Care Res (Hoboken); 2017 Feb; 69(2):263-270. PubMed ID: 27111848
[TBL] [Abstract][Full Text] [Related]
8. Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature.
Binns EL; Moraitis E; Maillard S; Tansley S; McHugh N; Jacques TS; Wedderburn LR; Pilkington C; Yasin SA; Nistala K;
Pediatr Rheumatol Online J; 2017 Oct; 15(1):77. PubMed ID: 29089059
[TBL] [Abstract][Full Text] [Related]
9. Immune-mediated necrotising myopathy associated with antibodies to the signal recognition particle treated with a combination of rituximab and cyclophosphamide.
Fernandes das Neves M; Caetano J; Oliveira S; Delgado Alves J
BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26240092
[TBL] [Abstract][Full Text] [Related]
10. Necrotising myopathy associated with anti-signal recognition particle (anti-SRP) antibody.
De Souza FHC; Miossi R; Shinjo SK
Clin Exp Rheumatol; 2017; 35(5):766-771. PubMed ID: 28281460
[TBL] [Abstract][Full Text] [Related]
11. Anti-synthetase syndrome associated with anti PL-12 and anti-Signal recognition particle antibodies and a necrotizing auto-immune myositis.
Malkan A; Cappelen-Smith C; Beran R; Griffith N; Toong C; Wang MX; Cordato D
J Clin Neurosci; 2015 Feb; 22(2):396-8. PubMed ID: 25150763
[TBL] [Abstract][Full Text] [Related]
12. The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature.
Barsotti S; Cioffi E; Tripoli A; Tavoni A; D'Ascanio A; Mosca M; Neri R
Reumatismo; 2018 Jul; 70(2):78-84. PubMed ID: 29976041
[TBL] [Abstract][Full Text] [Related]
13. Refractory Myositis Affecting the Intrinsic Muscles of the Hand.
Nakamura K; Sugai A; Saji E; Kasuga K; Onodera O
Intern Med; 2020 May; 59(9):1211-1214. PubMed ID: 31956201
[TBL] [Abstract][Full Text] [Related]
14. Anti-signal recognition particle autoantibody ELISA validation and clinical associations.
Aggarwal R; Oddis CV; Goudeau D; Fertig N; Metes I; Stephens C; Qi Z; Koontz D; Levesque MC
Rheumatology (Oxford); 2015 Jul; 54(7):1194-9. PubMed ID: 25524922
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study.
Picard C; Vincent T; Lega JC; Hue S; Fortenfant F; Lakomy D; Humbel RL; Goetz J; Molinari N; Bardin N; Bertin D; Johanet C; Chretien P; Dubucquoi S; Streichenberger N; Desplat-Jégo S; Bossuyt X; Sibilia J; Abreu I; Chevailler A; Fabien N
Immunol Res; 2016 Jun; 64(3):677-86. PubMed ID: 26744256
[TBL] [Abstract][Full Text] [Related]
16. Positive myositis-specific autoantibodies during COVID-19: a case report.
Abdelkrim AB; Ghozzi M; Saad G; Melayah S; Ach T; Ghedira I; Ach K
Pan Afr Med J; 2022; 43():181. PubMed ID: 36915412
[TBL] [Abstract][Full Text] [Related]
17. Poor response of anti-SRP-positive idiopathic immune myositis to B-cell depletion.
Whelan BR; Isenberg DA
Rheumatology (Oxford); 2009 May; 48(5):594-5. PubMed ID: 19254917
[No Abstract] [Full Text] [Related]
18. MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report.
Alqatari S; Riddell P; Harney S; Henry M; Murphy G
BMC Pulm Med; 2018 Apr; 18(1):59. PubMed ID: 29665800
[TBL] [Abstract][Full Text] [Related]
19. [Myositis-specific autoantibodies].
Gran JT; Molberg Ø; Dobloug GC; Andersson H; Taraldsrud E; Scheie D
Tidsskr Nor Laegeforen; 2009 Aug; 129(16):1631-4. PubMed ID: 19721478
[TBL] [Abstract][Full Text] [Related]
20. Myopathy associated with anti-signal recognition particle antibodies with pulmonary involvement and response to rituximab.
Mazeda C; Cunha R; Ferreira PG; Barcelos A; Aguiar R
Rheumatol Int; 2022 Jul; 42(7):1265-1269. PubMed ID: 34086073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
